GEn 1912
Alternative Names: GEn-1912Latest Information Update: 08 Mar 2024
At a glance
- Originator University of Maryland, Baltimore
- Developer GEn1E Lifesciences
- Class Antineoplastics
- Mechanism of Action Extracellular signal-regulated MAP kinase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Cancer